Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery
Objective ― This study was conducted to determine whether HbA1c is a predictor of short term mortality and morbidity after coronary artery bypass graft operation. Methods ― The coronary artery bypass graft operation was performed on the patients between January 2009 and January 2013. Each patient...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Limited liability company «Science and Innovations» (Saratov)
2015-05-01
|
Series: | Russian Open Medical Journal |
Subjects: | |
Online Access: | http://www.romj.org/node/125 |
id |
doaj-2c2c61df8d3b4f81b8d8feb6016dcfab |
---|---|
record_format |
Article |
spelling |
doaj-2c2c61df8d3b4f81b8d8feb6016dcfab2021-10-06T12:15:47ZengLimited liability company «Science and Innovations» (Saratov)Russian Open Medical Journal2304-34152015-05-0142e020410.15275/rusomj.2015.0204Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgeryÜmit ArslanMehmet Erdem MemetoğluRasim KutluOzan ErbasanMehmet TortEyüp Serhat ÇalıkZiya YıldızM. Ali KaygınOzan ErdemAli İhsan TekinObjective ― This study was conducted to determine whether HbA1c is a predictor of short term mortality and morbidity after coronary artery bypass graft operation. Methods ― The coronary artery bypass graft operation was performed on the patients between January 2009 and January 2013. Each patient's medical record was retrospectively reviewed. The patients who were included in the study were evaluated in groups of 60. One group was comprised of nondiabetic patients, whose HbA1c level is below 6% (the control group 0), the other included diabetic patients with the HbA1c level is between 6-6.9% (the group 1) and the last group, group 2, included those patients with HbA1c level is equal or greater than 7%. Pre, peri and post operation data was compared. The deaths that occured in the first 30 days were evaluated as mortality and complications as morbitity. Results ― While mortality was not observed in the control group, one incident was observed in group 1 and 5 in group 2, which corresponds to 1.7% and 8.3% respectively. The mortality ratio in the group with patients whose HbA1c was greater or equal to 7% found statistically significant compared to the control group (P=0.02). The following parameters were observed in group 2 and were found statistically significant: the need for dialisis (25%, P<0.01), atrial fibrillation (33%, P=0.01), revision due to bleeding (10%, P=0.18), cerebrovascular event (16,7%, P=0.01), duration of mechanic ventilation (19.5±21.6, P=0.06), duration of hospital stay (approximately 9.91±5.35 days, P=0.01), infection in scar (53%, P<0.01), mediastenit (11%, P=0.01) and urinary tract infection (10%, P=0.01) Conclusion ― We concluded that in those diabetic patients that elective coronart artery bypass graft is applied, highly reactive HbA1c levels (HbA1c ≥7), may indicate morbitity in the early stages of post operation.http://www.romj.org/node/125diabetes mellitusHbA1ccoronary artery bypass operationmorbiditymortality |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ümit Arslan Mehmet Erdem Memetoğlu Rasim Kutlu Ozan Erbasan Mehmet Tort Eyüp Serhat Çalık Ziya Yıldız M. Ali Kaygın Ozan Erdem Ali İhsan Tekin |
spellingShingle |
Ümit Arslan Mehmet Erdem Memetoğlu Rasim Kutlu Ozan Erbasan Mehmet Tort Eyüp Serhat Çalık Ziya Yıldız M. Ali Kaygın Ozan Erdem Ali İhsan Tekin Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery Russian Open Medical Journal diabetes mellitus HbA1c coronary artery bypass operation morbidity mortality |
author_facet |
Ümit Arslan Mehmet Erdem Memetoğlu Rasim Kutlu Ozan Erbasan Mehmet Tort Eyüp Serhat Çalık Ziya Yıldız M. Ali Kaygın Ozan Erdem Ali İhsan Tekin |
author_sort |
Ümit Arslan |
title |
Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery |
title_short |
Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery |
title_full |
Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery |
title_fullStr |
Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery |
title_full_unstemmed |
Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery |
title_sort |
preoperative hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery |
publisher |
Limited liability company «Science and Innovations» (Saratov) |
series |
Russian Open Medical Journal |
issn |
2304-3415 |
publishDate |
2015-05-01 |
description |
Objective ― This study was conducted to determine whether HbA1c is a predictor of short term mortality and morbidity after coronary artery bypass graft operation.
Methods ― The coronary artery bypass graft operation was performed on the patients between January 2009 and January 2013. Each patient's medical record was retrospectively reviewed. The patients who were included in the study were evaluated in groups of 60. One group was comprised of nondiabetic patients, whose HbA1c level is below 6% (the control group 0), the other included diabetic patients with the HbA1c level is between 6-6.9% (the group 1) and the last group, group 2, included those patients with HbA1c level is equal or greater than 7%. Pre, peri and post operation data was compared. The deaths that occured in the first 30 days were evaluated as mortality and complications as morbitity.
Results ― While mortality was not observed in the control group, one incident was observed in group 1 and 5 in group 2, which corresponds to 1.7% and 8.3% respectively. The mortality ratio in the group with patients whose HbA1c was greater or equal to 7% found statistically significant compared to the control group (P=0.02). The following parameters were observed in group 2 and were found statistically significant: the need for dialisis (25%, P<0.01), atrial fibrillation (33%, P=0.01), revision due to bleeding (10%, P=0.18), cerebrovascular event (16,7%, P=0.01), duration of mechanic ventilation (19.5±21.6, P=0.06), duration of hospital stay (approximately 9.91±5.35 days, P=0.01), infection in scar (53%, P<0.01), mediastenit (11%, P=0.01) and urinary tract infection (10%, P=0.01)
Conclusion ― We concluded that in those diabetic patients that elective coronart artery bypass graft is applied, highly reactive HbA1c levels (HbA1c ≥7), may indicate morbitity in the early stages of post operation. |
topic |
diabetes mellitus HbA1c coronary artery bypass operation morbidity mortality |
url |
http://www.romj.org/node/125 |
work_keys_str_mv |
AT umitarslan preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery AT mehmeterdemmemetoglu preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery AT rasimkutlu preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery AT ozanerbasan preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery AT mehmettort preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery AT eyupserhatcalık preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery AT ziyayıldız preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery AT malikaygın preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery AT ozanerdem preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery AT aliihsantekin preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery |
_version_ |
1716840828764160000 |